182 related articles for article (PubMed ID: 22645112)
1. Myotubular myopathy and the neuromuscular junction: a novel therapeutic approach from mouse models.
Dowling JJ; Joubert R; Low SE; Durban AN; Messaddeq N; Li X; Dulin-Smith AN; Snyder AD; Marshall ML; Marshall JT; Beggs AH; Buj-Bello A; Pierson CR
Dis Model Mech; 2012 Nov; 5(6):852-9. PubMed ID: 22645112
[TBL] [Abstract][Full Text] [Related]
2. Neuromuscular junction abnormalities in DNM2-related centronuclear myopathy.
Gibbs EM; Clarke NF; Rose K; Oates EC; Webster R; Feldman EL; Dowling JJ
J Mol Med (Berl); 2013 Jun; 91(6):727-37. PubMed ID: 23338057
[TBL] [Abstract][Full Text] [Related]
3. Impaired neuromuscular transmission and response to acetylcholinesterase inhibitors in centronuclear myopathies.
Robb SA; Sewry CA; Dowling JJ; Feng L; Cullup T; Lillis S; Abbs S; Lees MM; Laporte J; Manzur AY; Knight RK; Mills KR; Pike MG; Kress W; Beeson D; Jungbluth H; Pitt MC; Muntoni F
Neuromuscul Disord; 2011 Jun; 21(6):379-86. PubMed ID: 21440438
[TBL] [Abstract][Full Text] [Related]
4. β2-Adrenergic receptor agonists ameliorate the adverse effect of long-term pyridostigmine on neuromuscular junction structure.
Vanhaesebrouck AE; Webster R; Maxwell S; Rodriguez Cruz PM; Cossins J; Wickens J; Liu WW; Cetin H; Cheung J; Ramjattan H; Palace J; Beeson D
Brain; 2019 Dec; 142(12):3713-3727. PubMed ID: 31633155
[TBL] [Abstract][Full Text] [Related]
5. Characterization of neuromuscular synapse function abnormalities in multiple Duchenne muscular dystrophy mouse models.
van der Pijl EM; van Putten M; Niks EH; Verschuuren JJ; Aartsma-Rus A; Plomp JJ
Eur J Neurosci; 2016 Jun; 43(12):1623-35. PubMed ID: 27037492
[TBL] [Abstract][Full Text] [Related]
6. Effect of salbutamol on neuromuscular junction function and structure in a mouse model of DOK7 congenital myasthenia.
Webster RG; Vanhaesebrouck AE; Maxwell SE; Cossins JA; Liu W; Ueta R; Yamanashi Y; Beeson DMW
Hum Mol Genet; 2020 Aug; 29(14):2325-2336. PubMed ID: 32543656
[TBL] [Abstract][Full Text] [Related]
7. Continuous administration of pyridostigmine improves immobilization-induced neuromuscular weakness.
Frick CG; Helming M; Martyn JA; Blobner M; Fink H
Crit Care Med; 2010 Mar; 38(3):922-7. PubMed ID: 20009758
[TBL] [Abstract][Full Text] [Related]
8. PIK3C2B inhibition improves function and prolongs survival in myotubular myopathy animal models.
Sabha N; Volpatti JR; Gonorazky H; Reifler A; Davidson AE; Li X; Eltayeb NM; Dall'Armi C; Di Paolo G; Brooks SV; Buj-Bello A; Feldman EL; Dowling JJ
J Clin Invest; 2016 Sep; 126(9):3613-25. PubMed ID: 27548528
[TBL] [Abstract][Full Text] [Related]
9. Skeletal muscle IP3R1 receptors amplify physiological and pathological synaptic calcium signals.
Zhu H; Bhattacharyya BJ; Lin H; Gomez CM
J Neurosci; 2011 Oct; 31(43):15269-83. PubMed ID: 22031873
[TBL] [Abstract][Full Text] [Related]
10. Modeling the human MTM1 p.R69C mutation in murine Mtm1 results in exon 4 skipping and a less severe myotubular myopathy phenotype.
Pierson CR; Dulin-Smith AN; Durban AN; Marshall ML; Marshall JT; Snyder AD; Naiyer N; Gladman JT; Chandler DS; Lawlor MW; Buj-Bello A; Dowling JJ; Beggs AH
Hum Mol Genet; 2012 Feb; 21(4):811-25. PubMed ID: 22068590
[TBL] [Abstract][Full Text] [Related]
11. MuSK frizzled-like domain is critical for mammalian neuromuscular junction formation and maintenance.
Messéant J; Dobbertin A; Girard E; Delers P; Manuel M; Mangione F; Schmitt A; Le Denmat D; Molgó J; Zytnicki D; Schaeffer L; Legay C; Strochlic L
J Neurosci; 2015 Mar; 35(12):4926-41. PubMed ID: 25810523
[TBL] [Abstract][Full Text] [Related]
12. Muscle-specific kinase myasthenia gravis IgG4 autoantibodies cause severe neuromuscular junction dysfunction in mice.
Klooster R; Plomp JJ; Huijbers MG; Niks EH; Straasheijm KR; Detmers FJ; Hermans PW; Sleijpen K; Verrips A; Losen M; Martinez-Martinez P; De Baets MH; van der Maarel SM; Verschuuren JJ
Brain; 2012 Apr; 135(Pt 4):1081-101. PubMed ID: 22396395
[TBL] [Abstract][Full Text] [Related]
13. Neuromuscular synapse electrophysiology in myasthenia gravis animal models.
Plomp JJ; Huijbers MGM; Verschuuren JJGM
Ann N Y Acad Sci; 2018 Jan; 1412(1):146-153. PubMed ID: 29068559
[TBL] [Abstract][Full Text] [Related]
14. Loss of mitochondrial protein CHCHD10 in skeletal muscle causes neuromuscular junction impairment.
Xiao Y; Zhang J; Shu X; Bai L; Xu W; Wang A; Chen A; Tu WY; Wang J; Zhang K; Luo B; Shen C
Hum Mol Genet; 2020 Jul; 29(11):1784-1796. PubMed ID: 31261376
[TBL] [Abstract][Full Text] [Related]
15. Opposite Synaptic Alterations at the Neuromuscular Junction in an ALS Mouse Model: When Motor Units Matter.
Tremblay E; Martineau É; Robitaille R
J Neurosci; 2017 Sep; 37(37):8901-8918. PubMed ID: 28821658
[TBL] [Abstract][Full Text] [Related]
16. Reduced muscle strength in ether lipid-deficient mice is accompanied by altered development and function of the neuromuscular junction.
Dorninger F; Herbst R; Kravic B; Camurdanoglu BZ; Macinkovic I; Zeitler G; Forss-Petter S; Strack S; Khan MM; Waterham HR; Rudolf R; Hashemolhosseini S; Berger J
J Neurochem; 2017 Dec; 143(5):569-583. PubMed ID: 28555889
[TBL] [Abstract][Full Text] [Related]
17. Neuromuscular blocking effects of cisatracurium and its antagonism with neostigmine in a canine model of autosomal-recessive centronuclear myopathy.
Martin-Flores M; Paré MD; Campoy L; Gleed RD
Br J Anaesth; 2015 Dec; 115(6):927-31. PubMed ID: 26582854
[TBL] [Abstract][Full Text] [Related]
18. Loss of myotubularin function results in T-tubule disorganization in zebrafish and human myotubular myopathy.
Dowling JJ; Vreede AP; Low SE; Gibbs EM; Kuwada JY; Bonnemann CG; Feldman EL
PLoS Genet; 2009 Feb; 5(2):e1000372. PubMed ID: 19197364
[TBL] [Abstract][Full Text] [Related]
19. Tamoxifen therapy in a murine model of myotubular myopathy.
Maani N; Sabha N; Rezai K; Ramani A; Groom L; Eltayeb N; Mavandadnejad F; Pang A; Russo G; Brudno M; Haucke V; Dirksen RT; Dowling JJ
Nat Commun; 2018 Nov; 9(1):4849. PubMed ID: 30451841
[TBL] [Abstract][Full Text] [Related]
20. Reduced SMN protein impairs maturation of the neuromuscular junctions in mouse models of spinal muscular atrophy.
Kariya S; Park GH; Maeno-Hikichi Y; Leykekhman O; Lutz C; Arkovitz MS; Landmesser LT; Monani UR
Hum Mol Genet; 2008 Aug; 17(16):2552-69. PubMed ID: 18492800
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
